These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4074599)

  • 1. The pharmacokinetics of antipyrine in patients with graded severity of schistosomiasis.
    el-Raghy I; Back DJ; Osman F; Nafeh MA; Orme ML
    Br J Clin Pharmacol; 1985 Oct; 20(4):313-6. PubMed ID: 4074599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug metabolism in hepatosplenic schistosomiasis in the Sudan: a study with antipyrine.
    Homeida M; Salih SY; Branch RA
    Gut; 1978 Sep; 19(9):808-11. PubMed ID: 710970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered drug metabolism in hepatosplenic schistosomiasis.
    Brant PC; Prata A
    Rev Inst Med Trop Sao Paulo; 1979; 21(5):254-9. PubMed ID: 549210
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic profile of methotrexate and 5-fluorouracil in normal and bilharzial-infested mice.
    Osman AM; Saad SF; Saad SY; el-Aaser AB; el-Merzabani MM
    Chemotherapy; 1994; 40(4):227-31. PubMed ID: 8082409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefoperazone in normal subjects and patients with hepatosplenic schistosomiasis.
    Boscia JA; Korzeniowski OM; Kobasa WD; Rocha H; Levison ME; Kaye D
    J Antimicrob Chemother; 1983 Oct; 12(4):407-10. PubMed ID: 6643335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of antipyrine pharmacokinetics in saliva and plasma using a colourimetric method of antipyrine analysis.
    Harman AE; Priestly BG; Frewin DB
    Clin Exp Pharmacol Physiol; 1977; 4(6):593-6. PubMed ID: 589875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of fever on antipyrine metabolism in children.
    Forsyth JS; Moreland TA; Rylance GW
    Br J Clin Pharmacol; 1982 Jun; 13(6):811-5. PubMed ID: 7093111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saliva and plasma clearance of antipyrine as reflectors of liver function.
    Luoma PV; Sotaniemi EA
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.
    Harman AW; Penhall RK; Priestly BG; Frewin DB; Phillips PJ; Clarkson AR
    Aust N Z J Med; 1977 Aug; 7(4):385-90. PubMed ID: 270989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theophylline metabolism in patients with hepatosplenic mansoniasis and cirrhosis.
    Cukier A; Strauss E; Terra Filho M; Santos SR; Vargas FS
    J Hepatol; 1992 May; 15(1-2):35-9. PubMed ID: 1506654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis.
    Daneshmend TK; Homeida M; Kaye CM; Elamin AA; Roberts CJ
    Gut; 1982 Oct; 23(10):807-13. PubMed ID: 7117899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.
    Vesell ES; Passananti GT; Glenwright PA; Dvorchik BH
    Clin Pharmacol Ther; 1975 Sep; 18(3):259-72. PubMed ID: 1164816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol disposition in patients with hepatosplenic schistosomiasis.
    Homeida MM; Ali HM; Arbab BM; Harron DW
    Br J Clin Pharmacol; 1987 Sep; 24(3):393-6. PubMed ID: 3663453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipyrine metabolism in patients with diabetes mellitus.
    Murali KV; Adithan C; Shashindran CH; Gambhir SS; Chandrasekar S
    Clin Exp Pharmacol Physiol; 1983; 10(1):7-13. PubMed ID: 6839551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
    Rivière JH; Back DJ; Breckenridge AM; Howells RE
    Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipyrine clearance and metabolism in patients with psoriasis.
    Kubota K; Ishizaki T; Chiba K; Takagi A; Nakagawa A; Nakamura K
    Br J Clin Pharmacol; 1986 Oct; 22(4):455-62. PubMed ID: 3768257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity.
    Moreland TA; Park BK; Rylance GW
    Br J Clin Pharmacol; 1982 Dec; 14(6):861-5. PubMed ID: 6129885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxamniquine pharmacokinetics in hepatosplenic schistosomiasis in the Sudan.
    Daneshmend TK; Homeida MA
    J Antimicrob Chemother; 1987 Jan; 19(1):87-93. PubMed ID: 3104279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary antipyrine half-life during injectable progestagen contraception.
    Joshi JV; Gupta KC; Hazari KT; Gokral J; Pohujani S; Satoskar R
    Clin Pharmacokinet; 1986; 11(2):171-5. PubMed ID: 3956050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipyrine pharmacokinetics in the pregnant rat.
    Dean M; O'Donnell L; Penglis S; Stock B
    Drug Metab Dispos; 1980; 8(4):265-7. PubMed ID: 6105062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.